e.g. mhealth
Search Results (1 to 10 of 60 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 17 JMIR Cancer
- 16 JMIR Research Protocols
- 12 Journal of Medical Internet Research
- 4 JMIR mHealth and uHealth
- 3 JMIRx Med
- 2 JMIR Medical Informatics
- 2 Journal of Participatory Medicine
- 1 JMIR Formative Research
- 1 JMIR Medical Education
- 1 JMIR Mental Health
- 1 JMIR Public Health and Surveillance
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Serious Games
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Go back to the top of the page Skip and go to footer section
Neoplasms (cancers) accounted for approximately 27.1% (95% UI 28.6%-24.3%) of total deaths in Western Europe. The age-standardized death rate for neoplasms in the region was 125.8 per 100,000 population (95% UI 131.4-115.3) in the same year (Tables 1 and 2). The 3 cancer subtypes with the highest death burden in Western Europe in 2021 were lung cancer, colorectal cancer, and breast cancer (Table 2). The death burden of neoplasms in Western Europe has also shown a downward trend from 1990 to 2021.
JMIR Public Health Surveill 2024;10:e57840
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Intensive Longitudinal Methods Among Adults With Breast or Lung Cancer: Scoping Review
neoplasms
J Med Internet Res 2024;26:e50224
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
The increased popularity of GLP-1 RAs and the unsettled association of thyroid hyperplasias and neoplasms prompted further investigation into the most recent US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) data sets. In this study, we evaluated thyroid hyperplasia and neoplasm–related AEs that are reported as being associated with GLP-1 RA monotherapy when compared to sodium-glucose cotransporter-2 (SGLT-2) inhibitors monotherapy.
JMIRx Med 2024;5:e55976
Download Citation: END BibTex RIS
Helicobacter pylori is involved in and induces the early stages of gastric carcinogenesis, which begin with chronic gastritis and progress to atrophy, intestinal metaplasia (IM), and the development of gastric neoplasms [1,2]. Although H. pylori eradication reduces the risk of developing gastric cancer, the risk persists even after eradication, particularly in patients with advanced atrophy or IM in the stomach [3,4]. The primary goal of screening endoscopy is to detect neoplastic lesions in the stomach.
J Med Internet Res 2023;25:e50448
Download Citation: END BibTex RIS